🌼
Feverfew
Tanacetum parthenium
Anti-tumourmoderate evidence
Parthenolide from feverfew is one of the most potent natural eliminators of cancer stem cells — a major breakthrough since cancer stem cells drive recurrence and resistance to chemotherapy. Studies show parthenolide selectively destroys leukemia stem cells while leaving normal stem cells intact. NF-κB inhibition and apoptosis induction are key mechanisms.
Medicinal Properties
Anti-tumourAnti-inflammatoryAntiplateletAnalgesicMigraine relief
🎗️
Cancer Types Studied
LeukemiaBreastColonPancreatic
Recommended Dosage
125–250 mg standardised extract (0.2–0.4% parthenolide) twice daily.
Preparations
Standardised Capsules
125–250 mg feverfew extract standardised to parthenolide content twice daily with food.
NIH / PubMed Research
Links open on PubMed (National Library of Medicine). Research is ongoing — results may not reflect clinical use.
Cautions & Interactions
- Do not use in pregnancy — may stimulate uterine contractions
- May increase bleeding risk — stop before surgery
- May cause 'post-feverfew syndrome' on abrupt discontinuation (rebound headache)
- Interaction with anticoagulants and NSAIDs
Related Herbs
Informational only. Not medical advice. Consult your healthcare provider before use.